Tonic inhibitory effects of endocannabinoids on human skin mast cellfunctions in situ by cannabinoid receptor 1 (CB1)-mediated signalling

被引:0
|
作者
Sugawara, K. [1 ]
Br, T. [2 ]
Kromminga, A. [3 ]
Tsuruta, D. [4 ]
Tth, B. I. [2 ]
Zimmer, A. [5 ]
Gibbs, B. F. [6 ]
Paus, R. [1 ,7 ]
机构
[1] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany
[2] Univ Debrecen, Dept Physiol, H-4012 Debrecen, Hungary
[3] Inst Immunol, Hamburg, Germany
[4] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 558, Japan
[5] Univ Bonn, Inst Mol Psychiat, Life & Brain Ctr, D-5300 Bonn, Germany
[6] Univ Kent, Medway Sch Pharm, Canterbury CT2 7NZ, Kent, England
[7] Univ Manchester, Sch Translat Med, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P037
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [41] CB1 receptor independent inhibitory effects of cannabinoid agonists on the release of [3H]GABA from hippocampal synaptosomes in the CB1 knockout mice
    Ando, R.
    Biro, J.
    Sperlagh, B.
    ACTA PHYSIOLOGICA HUNGARICA, 2010, 97 (04) : 423 - 423
  • [42] Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer
    Lynch, Diane L.
    Reggio, Patricia H.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (7-8) : 495 - 509
  • [43] Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer
    Diane L. Lynch
    Patricia H. Reggio
    Journal of Computer-Aided Molecular Design, 2006, 20 : 495 - 509
  • [44] Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
    Arguello, PA
    Jentsch, JD
    PSYCHOPHARMACOLOGY, 2004, 177 (1-2) : 141 - 150
  • [45] EXPRESSION OF CANNABINOID 1 (CB1) AND CANNABINOID 2 (CB2) RECEPTOR AND EFFECTS OF CB1/CB2 RECEPTOR AGONISTS ON DETRUSOR OVERACTIVITY ASSOCIATED WITH BLADDER OUTLET OBSTRUCTION IN RATS
    Cho, K. J.
    Kim, S. D.
    Seo, J. T.
    Kim, S. H.
    Kim, J. C.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 926 - 927
  • [46] The cardiopulmonary effects of a cannabinoid 1 receptor (CB1) agonist is mediated by the transient receptor potential vanilloid 1 (TRPV1) channel
    Smith, SG
    Vincent, SG
    Barrette, VF
    Fisher, JT
    CHEST, 2005, 128 (04) : 387S - 388S
  • [47] Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin
    Leonti, Marco
    Casu, Laura
    Raduner, Stefan
    Cottiglia, Filippo
    Floris, Costantino
    Altmann, Karl-Heinz
    Gertsch, Juerg
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (12) : 1815 - 1826
  • [48] CB1 cannabinoid receptor and cannabinoid receptor interacting protein in human myometrium and placenta during labor
    Kozakiewicz, Melissa L.
    Zhang, Jie
    Leone-Kabler, Sandra
    Yamaleyeva, Liliya M.
    Brost, Brian C.
    Howlett, Allyn C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S560 - S561
  • [49] The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
    Tharp, William G.
    Lee, Yong-Ho
    Maple, Rhonda L.
    Pratley, Richard E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (04) : 595 - 600
  • [50] Recent advances in CB1 cannabinoid receptor antagonists
    Lange, JHM
    Kruse, CG
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (04) : 498 - 506